Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study

International Journal of Clinical Practice

Volumn 70, Issue 7, 2016, Pages 569-576

  Sardu, C ^a,b   Santamaria, M ^a   Rizzo, M R ^b   Barbieri, M ^b   di Marino, M ^a   Paolisso, G ^b   Santulli, G ^c   Marfella, R ^b  

^a John Paul II Research and Care Foundation   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BISOPROLOL; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IVABRADINE; ORAL ANTIDIABETIC AGENT; SARTAN DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TELEMONITORING; TREATMENT OUTCOME;

EID: 84977562742     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12823     Document Type: Article

References (35)

1. Inglis SC, Clark RA, Dierckx R et al. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 2015; 10: CD007228.
2. Kotooka N, Asaka M, Sato Y et al. Home telemonitoring study for Japanese patients with heart failure (HOMES-HF): protocol for a multicentre randomised controlled trial. BMJ Open 2013; 3: e002972.
3. Hasan A, Paul V. Telemonitoring in chronic heart failure. Eur Heart J 2011; 32: 1457–64.
4. Halimi F, Clementy J, Attuel P et al. Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial. Europace 2008; 10: 1392–9.
5. Houston BA, Kalathiya RJ, Kim DA, Zakaria S. Volume overload in heart failure: an evidence-based review of strategies for treatment and prevention. Mayo Clin Proc 2015; 90: 1247–61.
6. Hutchinson K, Pellicori P, Dierckx R et al. Remote telemonitoring for patients with heart failure: might monitoring pulmonary artery pressure become routine? Expert Rev Cardiovasc Ther 2014; 12: 1025–33.
7. Heidbuchel H, Hindricks G, Broadhurst P et al. EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring. Eur Heart J 2015; 36: 158–69.
8. Hindricks G, Taborsky M, Glikson M et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 2014; 384: 583–90.
9. Dubner S, Auricchio A, Steinberg JS et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Ann Noninvasive Electrocardiol 2012; 17: 36–56.
10. Ong MK, Romano PS, Edgington S et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the better effectiveness after transition-heart failure (BEAT-HF) randomized clinical trial. JAMA Intern Med 2016; 176: 310–8.
11. Chaudhry SI, Mattera JA, Curtis JP et al. Telemonitoring in patients with heart failure. N Engl J Med 2010; 363: 2301–9.
12. Myrvang H. Automatic remote home monitoring is a safe option for ICD follow-up. Nat Rev Cardiol 2010; 7: 541.
13. Moss AJ, Hall WJ, Cannom DS et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329–38.
14. Sardu C, Marfella R, Santulli G, Paolisso G. Functional role of miRNA in cardiac resynchronization therapy. Pharmacogenomics 2014; 15: 1159–68.
15. Santulli G, D'Ascia C. Atrial remodelling in echocardiographic super-responders to cardiac resynchronization therapy. Heart 2012; 98: 517.
16. D'Ascia SL, D'Ascia C, Marino V et al. Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy. Int J Clin Pract 2011; 65: 1149–55.
17. Friedman DJ, Upadhyay GA, Rajabali A et al. Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes. Heart Rhythm 2014; 11: 1991–8.
18. Tracy CM, Epstein AE, Darbar D et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012; 60: 1297–313.
19. Arya A, Block M, Kautzner J et al. Influence of Home Monitoring on the clinical status of heart failure patients: design and rationale of the IN-TIME study. Eur J Heart Fail 2008; 10: 1143–8.
20. Varma N, Epstein AE, Irimpen A et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010; 122: 325–32.
21. Lamas GA, Lee K, Sweeney M et al. The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J 2000; 140: 541–51.
22. Kutalek SP, Sharma AD, McWilliams MJ et al. Effect of pacing for soft indications on mortality and heart failure in the dual chamber and VVI implantable defibrillator (DAVID) trial. Pacing Clin Electrophysiol 2008; 31: 828–37.
23. Vanderheyden M, Mullens W, Delrue L et al. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol 2008; 51: 129–36.
24. Anand IS, Carson P, Galle E et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation 2009; 119: 969–77.
25. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140–50.
26. Moss AJ, Greenberg H, Case RB et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004; 110: 3760–5.
27. January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130: e199–267.
28. Sardu C, Marfella R, Santulli G. Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people. J Cardiovasc Transl Res 2014; 7: 362–8.
29. Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 2013; 113: 739–53.
30. Santulli G, Iaccarino G. Adrenergic signaling in heart failure and cardiovascular aging. Maturitas 2016; doi:10.1016/j.maturitas.2016.03.022. in press.
31. Hatton R, Cvjeticanin A, Lymperopoulos A. The adrenergic system of the adrenal glands as a remote control of cardiac function. J Cardiovasc Dis 2015; 5: 394–7.
32. Santulli G. Adrenal signaling in heart failure: something more than a distant ship's smoke on the horizon. Hypertension 2014; 63: 215–6.
33. Lymperopoulos A, Chowdhary S, Sankar K, Simon I. Regulation of Catecholamine Production from the Adrenal Medulla. In: Santulli G, ed. Adrenal Glands: from Pathophysiology to Clinical Evidence. New York: NY Nova Science Publisher, 2015.
34. Santulli G. beta-Blockers in diabetic patients with heart failure. JAMA Intern Med 2015; 175: 657.
35. Scholtens AM, Braat AJ, Tuinenburg A et al. Cardiac sympathetic innervation and cardiac resynchronization therapy. Heart Fail Rev 2014; 19: 567–73.